Farmaseuttisten biotieteiden osastolla tutkimusta tehdään useissa tutkimusryhmissä ja usein tiiviissä yhteistyössä kansallisten ja kansainvälisten laboratorioiden tai lääkeyhtiöiden kanssa.
Farmaseuttisten biotieteiden tutkimusryhmät

Tutkimusosastolla kokonaan tai osittain toimivat tutkimusryhmät aakkosjärjestyksessä.

Kansainvälisen tutkimuksen kieli on englanti, joten tutkimusryhmien sivustot ovat englanninkielisiä.


Bioactivity Screening

Group Leader Päivi Tammela

We are experts in antimicrobial drug discovery, exploring new ways to confront the global challenge of emerging drug resistance amongst bacteria.


Group leader Marjo Yliperttula

The focal point of Biopharmaceutics group research is the development of the biomaterials for cell culture, drug delivery, and tissue repair together with the relevant detection technology. The developed materials are based on the nanofibrillated cellulose, nanoparticles, and extracellular vesicles.


Drug Delivery Unit

Group Leader Arto Urtti

Optimal delivery of drugs to their target sites is essential for drug efficacy and safety. Drug delivery unit explores the key pharmacokinetic factors in drug delivery as well as new technologies for delivering drugs, especially to the eyes.


ImmunoViroTherapy Lab

Group Leader Vincenzo Cerullo

Development of novel platforms for cancer immunotherapy.


Lymphangiogenesis Research and Antibody Development

Group Leader Michael Jeltsch

We do biomedical research in vascular biology (lymphangiogenesis, VEGF-C) and antibody technology development.


Phar­ma­ceut­ical nanotechnology

Group Leader Timo Laaksonen

We work on controlled drug release and delivery using modern methods and materials.


See also Drug Research Program Units

Drug Research Program (DRP) is a unique multidisciplinary platform that combines research groups with expertise on different aspects of drug research.